SOLU-CORTEF (hydrocortisone sodium succinate)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+57
Pfizer Laboratories
Indication
Synovitis
Synovitis is the inflammation of the synovial membrane, the specialized mesenchymal tissue lining diarthrodial joints, bursae, and tendon sheaths. Read more about Synovitis
242 drugs 127 manufacturers
Drugs that treat it
Common Synovitis therapies.
SOLU-MEDROL (methylprednisolone sodium succinate)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+52
Pfizer Laboratories
DEPO-MEDROL (methylprednisolone acetate)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+43
Pfizer Laboratories
HYDROCORTISONE
TRICHINOSIS·+51
VENSUN PHARMACE
MEDROL (methylprednisolone)
GLUCOCORTICOSTEROIDS·DISSEMINATED TUBERCULOSIS·+55
Pfizer Laboratories
METHYLPREDNISOLONE
DISSEMINATED TUBERCULOSIS·+55
QUALITEST/PAR P
METHYLPREDNISOLONE
DISSEMINATED TUBERCULOSIS·+55
Actavis Pharma
CORTEF (hydrocortisone)
GLUCOCORTICOSTEROIDS·TRICHINOSIS·+51
Pfizer Laboratories
INDOMETHACIN ER (indomethacin)
NON-STEROIDAL ANTI-INFLAMMATORY (NSAID) AND SALICYLATES·GOUT·+9
AUROBINDO PHARM
Filter & compare in the drug finder →Opens the drug finder with Synovitis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSynovitis is the inflammation of the synovial membrane, the specialized mesenchymal tissue lining diarthrodial joints, bursae, and tendon sheaths.
It primarily affects the musculoskeletal system across diverse patient populations and can arise secondary to autoimmune diseases like rheumatoid arthritis, crystal deposition disorders, infection, trauma, or degenerative osteoarthritis.
Pathophysiologically, the condition is characterized by synovial lining hyperplasia, increased vascularity, and infiltration of mononuclear inflammatory cells, which promotes joint effusion and enzymatic cartilage degradation.
Clinically, affected patients present with localized joint pain, swelling, warmth, and stiffness, often accompanied by restricted range of motion.
- nih.gov
Synovitis is the inflammation of the synovial membrane, the specialized mesenchymal tissue lining diarthrodial joints, bursae, and tendon sheaths Pathophysiologically, the condition is characterized by synovial lining hyperplasia, increased vascularity, and infiltration of mononuclear inflammatory cells, which promotes joint effusion and enzymatic cartilage degradation
- nih.gov
It primarily affects the musculoskeletal system across diverse patient populations and can arise secondary to autoimmune diseases like rheumatoid arthritis, crystal deposition disorders, infection, trauma, or degenerative osteoarthritis Clinically, affected patients present with localized joint pain, swelling, warmth, and stiffness, often accompanied by restricted range of motion
- nih.gov
It primarily affects the musculoskeletal system across diverse patient populations and can arise secondary to autoimmune diseases like rheumatoid arthritis, crystal deposition disorders, infection, trauma, or degenerative osteoarthritis
- nih.gov
It primarily affects the musculoskeletal system across diverse patient populations and can arise secondary to autoimmune diseases like rheumatoid arthritis, crystal deposition disorders, infection, trauma, or degenerative osteoarthritis Pathophysiologically, the condition is characterized by synovial lining hyperplasia, increased vascularity, and infiltration of mononuclear inflammatory cells, which promotes joint effusion and enzymatic cartilage degradation
- medlineplus.gov
It primarily affects the musculoskeletal system across diverse patient populations and can arise secondary to autoimmune diseases like rheumatoid arthritis, crystal deposition disorders, infection, trauma, or degenerative osteoarthritis
- nih.gov
Clinically, affected patients present with localized joint pain, swelling, warmth, and stiffness, often accompanied by restricted range of motion
- nih.gov
Clinically, affected patients present with localized joint pain, swelling, warmth, and stiffness, often accompanied by restricted range of motion
- medlineplus.gov
Clinically, affected patients present with localized joint pain, swelling, warmth, and stiffness, often accompanied by restricted range of motion
Personalize your experience
Follow Synovitis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.